VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial

agilon health Executive Compensation (FY25)

AGL · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Jeffrey Schwaneke
Latest say-on-pay support
=
June 2, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The agilon health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 25, 2026Latest filing (8-K): June 3, 2026
9 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
agilon health brief$500Get the executive brief
Velarion Intel, one year, every company
291 figures on this page: 286 cited to the filing that reported them, 5 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Jeffrey Schwaneke: $7,136,122 → $5,610,878 (21.4% lower)
CEO pay ratio: 96:1 → 82:1 (14.6% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is agilon health's chief executive and what were they paid?
Jeffrey Schwaneke, Chief Financial Officer and Interim Co-Principal Executive Officer, received $5,610,878 in total compensation for fiscal 2025. Schwaneke's total moved 21.4% lower from the $7,136,122 reported for fiscal 2024.
What was agilon health's say-on-pay result?
The say-on-pay proposal drew 94.7% of votes cast for or against in favor at the meeting held June 2, 2026 for fiscal 2025.
Which companies are in agilon health's peer group?
Companies named in the disclosed peer group include Alignment Healthcare, Inc., Astrana Health, Inc., Certara, Inc., DaVita Inc. and Doximity, Inc., among others.
What is agilon health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 82:1, against median employee compensation of $68,133.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Steven Sell
Chief Executive Officer and President
◇—◇◇◇—◇◇
Veeral Desai
Chief Strategy and Development Officer
◇—◇◇◇—◇◇
Timothy Bensley
Chief Financial Officer
◇—◇◇◇——◇
Benjamin Shaker
Chief Markets Officer
◇—◇◇◇—◇◇
Girish Venkatachaliah
Chief Technology Officer
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Steven Sell
Former Chief Executive Officer and President
◇—◇◇——◇◇
Veeral Desai
Chief Strategy and Development Officer
◇—◇◇——◇◇
Benjamin Shaker
Chief Markets Officer and Interim Co-Principal Executive Officer
Served on an interim basis
◇—◇◇——◇◇
Girish Venkatachaliah
Chief Technology Officer
◇—◇◇——◇◇
Timothy Bensley
Chief Financial Officer
◇—◇◇———◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jeffrey Schwaneke
Chief Financial Officer
Served on an interim basis
◇—◇◇◇—◇◇
Steven Sell
Chief Executive Officer and President
◇—◇◇◇—◇◇
Veeral Desai
Former Chief Strategy and Development Officer
Departed during or after this year
◇—◇◇◇—◇◇
Benjamin Shaker
Chief Markets Officer
Served on an interim basis
◇—◇◇◇—◇◇
Girish Venkatachaliah
Chief Technology Officer
◇—◇◇◇—◇◇
Timothy Bensley
Former Chief Financial Officer
Departed during or after this year
◇——————◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Steven Sell
Former Chief Executive Officer and President
Departed during or after this year
◇—◇◇——◇◇
Jeffrey Schwaneke
Chief Financial Officer and Interim Co-Principal Executive Officer
Served on an interim basis
◇—◇◇◇—◇◇
Benjamin Shaker
Chief Markets Officer and Interim Co-Principal Executive Officer
Served on an interim basis
◇—◇◇◇—◇◇
Denise Zamore
Chief Legal Officer and Corporate Secretary
◇—◇◇◇—◇◇
Girish Venkatachaliah
Chief Technology Officer
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Benjamin ShakerRSU◇——◇——◇
Benjamin ShakerOPTION◇——◇—◇◇
Benjamin ShakerPSU◇◇◇—◇—◇
Denise ZamoreRSU◇——◇——◇
Denise ZamorePSU◇◇◇—◇—◇
Denise ZamoreOPTION◇——◇—◇◇
Girish VenkatachaliahRSU◇——◇——◇
Girish VenkatachaliahPSU◇◇◇—◇—◇
Girish VenkatachaliahOPTION◇——◇—◇◇
Jeffrey SchwanekeOPTION◇——◇—◇◇
Jeffrey SchwanekePSU◇◇◇—◇—◇
Jeffrey SchwanekeRSU◇——◇——◇
Steven SellOPTION◇——◇—◇◇
Steven SellPSU◇◇◇—◇—◇
Steven SellRSU◇——◇——◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Benjamin ShakerOption◇—◇4/1/2035
RSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇4/15/2034
RSU◇◇——
RSU◇◇——
RSU◇◇——
Jeffrey SchwanekeOption◇—◇4/1/2035
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
Option◇—◇7/1/2034
PSU◇◇——
RSU◇◇——
Denise ZamoreOption◇—◇4/1/2035
RSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇4/15/2034
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Girish VenkatachaliahPSU◇◇——
Option◇—◇4/1/2035
Option◇—◇4/15/2034
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Benjamin Shaker
Chief Markets Officer and Interim Co-Principal Executive Officer · Employment agreement
Severance multiple◇
Denise Zamore
Chief Legal Officer and Corporate Secretary · Employment agreement
Severance multiple◇
Girish Venkatachaliah
Chief Technology Officer · Employment agreement
Severance multiple◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Karen McLoughlin
◇◇————◇
Diana L. McKenzie
◇◇————◇
William Wulf, M.D
◇◇————◇
Sharad Mansukani, M.D
◇◇————◇
Silvana Battaglia
◇◇————◇
Ron Williams
—◇————◇
Ravi Sachdev, Jeffrey A. Schwaneke and Steven J. Sell served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Stock ownership guideline: Non-Employee Directors* 5x Annual Board Cash Retainer

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alignment Healthcare, Inc. ALHC
  • Astrana Health, Inc. ASTH
  • Certara, Inc. CERT
  • DaVita Inc. DVA
  • Doximity, Inc. DOCS
  • Evolent Health, Inc. EVH
  • GoodRx Holdings, Inc. GDRX
  • Guardant Health, Inc. GH
  • HealthEquity, Inc. HQY
  • LifeStance Health Group, Inc. LFST
  • Privia Health Group, Inc. PRVA
  • Progyny, Inc. PGNY
  • Quest Diagnostics, Inc. DGX
  • R1 RCM Inc. RCM
  • Teladoc Health, Inc. TDOC
  • Veeva Systems, Inc. VEEV

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 2, 2026=◇◇◇
2024May 28, 2025=◇◇◇
2023May 29, 2024=◇◇◇
2022May 24, 2023=◇◇◇
2021May 24, 2022=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Benjamin Shaker (Chief Markets Officer and Interim Co-Principal Executive Officer), FY2025 total compensation $5,357,548 (base salary $450,000) [exec_comp, SEC accession 0001628280-26-026544, filed 2026-04-22]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when agilon health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact agilon health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where agilon health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether agilon health's disclosed peer group is defensible, who names agilon health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
291 figures on this page: 286 cited to the filing that reported them, 5 calculated from figures it prints.
286 cited to the filing
5 calculated from the filing

Documents cited

  1. 0001628280-26-040370
  2. 0001628280-26-026544
    Compensation Table · Director Compensation · Potential Payments Upon Termination
  3. 0001628280-25-028631
  4. 0001140361-25-014418
  5. 0001628280-24-026327
  6. 0001140361-24-020533
    Summary Compensation Table
  7. 0000950170-23-024240
  8. 0001140361-23-018402
    Summary Compensation Table
  9. 0000950170-22-010569
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “agilon health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/AGL (accessed 2026).
Short form: data: Velarion

The agilon health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about agilon health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers agilon health discloses

The companies named in AGL's own disclosed peer group.

Alignment Healthcare, Inc.Astrana Health, Inc.Certara, Inc.DaVita Inc.Doximity, Inc.Evolent Health, Inc.GoodRx Holdings, Inc.Guardant Health, Inc.HealthEquity, Inc.LifeStance Health Group, Inc.Privia Health Group, Inc.Progyny, Inc.Quest Diagnostics, Inc.R1 RCM Inc.Teladoc Health, Inc.Veeva Systems, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy